+ All Categories
Home > Health & Medicine > Metabolic Bone Disease

Metabolic Bone Disease

Date post: 12-May-2015
Category:
Upload: andre-garcia
View: 8,527 times
Download: 1 times
Share this document with a friend
Description:
FREE Medical eBooks => http://asgarcymed.blogspot.com/
Popular Tags:
56
Metabolic Bone Metabolic Bone Disease Disease Munro Peacock Munro Peacock
Transcript
Page 1: Metabolic Bone Disease

Metabolic Bone Metabolic Bone DiseaseDiseaseMunro PeacockMunro Peacock

Page 2: Metabolic Bone Disease

Metabolic Bone DiseaseMetabolic Bone Disease

GeneralizedGeneralized Bone turnover affectedBone turnover affected Not infectionsNot infections Not primary bone neoplastic diseaseNot primary bone neoplastic disease

Page 3: Metabolic Bone Disease

Metabolic Bone DiseasesMetabolic Bone Diseases

Mineralization; osteomalacia/ricketsMineralization; osteomalacia/rickets Bone turnover; pagets; primary Bone turnover; pagets; primary

hyperparthyroidism; secondary hyperparthyroidism; secondary hyperparathyroidismhyperparathyroidism

Low Bone content; osteoporoses/ Low Bone content; osteoporoses/ generalized and localized; oi; generalized and localized; oi;

High bone content; osteopetrosisHigh bone content; osteopetrosis

Page 4: Metabolic Bone Disease

Metabolic Bone DiseasesMetabolic Bone Diseases

Mineralization; osteomalacia/ricketsMineralization; osteomalacia/rickets Low bone mineral content; osteoporoses; OILow bone mineral content; osteoporoses; OI High bone mineral content; osteopetrosis; High bone mineral content; osteopetrosis;

bisphosphonate; benign high bone massbisphosphonate; benign high bone mass High bone turnover; pagets; High bone turnover; pagets;

hyperparathyroidismhyperparathyroidism Low bone turnover; adynamic diseaseLow bone turnover; adynamic disease

Page 5: Metabolic Bone Disease

FractureFracture

TraumaTrauma Decreased bone strengthDecreased bone strength

Page 6: Metabolic Bone Disease

Diseases of Mineralization: Diseases of Mineralization: Osteomalacia and RicketsOsteomalacia and Rickets

Osteomalacia is a term that is used to Osteomalacia is a term that is used to encompass a group of diseases in adults, encompass a group of diseases in adults, the essential feature of which is a delay in the essential feature of which is a delay in mineralization as osteoid is laid down.mineralization as osteoid is laid down.

Rickets is the equivalent term used in Rickets is the equivalent term used in children where the disease manifests children where the disease manifests particularly at the growth areas of bone particularly at the growth areas of bone

Page 7: Metabolic Bone Disease

Mineralization CalcificationMineralization Calcification

Page 8: Metabolic Bone Disease

Osteomalacia and RicketsOsteomalacia and Rickets

Disease is diagnosed by histology and in Disease is diagnosed by histology and in sever cases by radiologysever cases by radiology

Etiology is diagnosed by biochemistry, Etiology is diagnosed by biochemistry, history and examinationhistory and examination

Page 9: Metabolic Bone Disease

Osteomalacia and RicketsOsteomalacia and Rickets

Vitamin DVitamin D PhosphatePhosphate CalciumCalcium AcidAcid Alkaline PhosphateAlkaline Phosphate Drugs and ToxinsDrugs and Toxins

Page 10: Metabolic Bone Disease

Vitamin DVitamin D

Vitamin D DeficiencyVitamin D Deficiency Impaired 25 OH Vitamin D productionImpaired 25 OH Vitamin D production Impaired 1,25 OH2 Vitamin D productionImpaired 1,25 OH2 Vitamin D production Defective Vitamin D receptor Defective Vitamin D receptor

Page 11: Metabolic Bone Disease

Vitamin D DeficiencyVitamin D Deficiency

EnvironmentalEnvironmentalhousebound; frail elderly; immigrant from housebound; frail elderly; immigrant from

low low to high latitude; gastrectomy; to high latitude; gastrectomy; malabsorptionmalabsorption

GeneticGeneticdark skin pigmentationdark skin pigmentation

BiochemistryBiochemistryD low; 25D low; 1,25D low to normal ; Ca D low; 25D low; 1,25D low to normal ; Ca low; PTH high; Alk Ph high; P low low; PTH high; Alk Ph high; P low

Page 12: Metabolic Bone Disease

Impaired 25D productionImpaired 25D production

EnvironmentalEnvironmentalhepatic failure; drugs affecting CYP liver hepatic failure; drugs affecting CYP liver enzymesenzymes

Genetic Genetic mutations in 25Dhydroxylase: not mutations in 25Dhydroxylase: not describeddescribed

BiochemistryBiochemistryD normal; 25D low; 1,25 D low to normal; D normal; 25D low; 1,25 D low to normal; Ca low; PTH high; Alk ph high; P lowCa low; PTH high; Alk ph high; P low

Page 13: Metabolic Bone Disease

Impaired 1,25 D productionImpaired 1,25 D production

EnvironmentalEnvironmentalchronic renal failurechronic renal failure

GeneticGeneticmutations in 25D 1 alpha mutations in 25D 1 alpha hydroxylase hydroxylase (D (D dependent rickets type 1)dependent rickets type 1)

BiochemistryBiochemistryD normal; 25D normal; 1,25D low; Ca low; D normal; 25D normal; 1,25D low; Ca low; PTH high; Alk Ph high; P high in CRF and PTH high; Alk Ph high; P high in CRF and low in D dependent ricketslow in D dependent rickets

Page 14: Metabolic Bone Disease

0.4

0.6

0.8

1.0

1.2

1.4

0 10 20 30 40 50 60 70 80

0.4

0.6

0.8

1.0

1.2

1.4

0 10 20 30 40 50 60 70 80

BMD, g/cm2

0.4

0.6

0.8

1.0

1.2

1.4

0 10 20 30 40 50 60 70 80

Age

TOTAL BODY FEMORAL NECK LUMBAR SPINE

Change in BMD (mean ± 1SD) with age in healthy male (--) and female (--)(DPX, Lunar)

Page 15: Metabolic Bone Disease

Defective D receptor (VDR)Defective D receptor (VDR)

EnvironmentalEnvironmentalnon describednon described

GeneticGeneticmutations in VDR ( D dependent mutations in VDR ( D dependent rickets rickets

type 2) type 2) BiochemistryBiochemistry

D normal; 25D normal; 1,25D high; Ca D normal; 25D normal; 1,25D high; Ca low; PTH high; Alk Ph high; P lowlow; PTH high; Alk Ph high; P low

Page 16: Metabolic Bone Disease

PhosphatePhosphate

EnvironmentalEnvironmentaldietary phosphate depletion; dietary phosphate depletion; prematurity in neonates; prematurity in neonates; mesenchymal mesenchymal tumors; renal tubule tumors; renal tubule diseasedisease

GeneticGeneticmutations in mutations in PHEXPHEX; mutations in ; mutations in FGFFGF

Page 17: Metabolic Bone Disease

Dietary Phosphate DepletionDietary Phosphate Depletion

Page 18: Metabolic Bone Disease

Phosphate: Dietary P depletionPhosphate: Dietary P depletion

Abuse of oral P binders (Aludrox)Abuse of oral P binders (Aludrox) BiochemistryBiochemistry

P low; TmP normal; Ca high; urine P low; TmP normal; Ca high; urine Ca high; PTH low; Alk Ph normal; D Ca high; PTH low; Alk Ph normal; D normal; 25D normal; 1,25D highnormal; 25D normal; 1,25D high

Page 19: Metabolic Bone Disease

Phosphate: Neonatal PrematurityPhosphate: Neonatal Prematurity

Dietary P insufficiencyDietary P insufficiencymilk P intake inadequate for the milk P intake inadequate for the

requirements of a rapidly developing requirements of a rapidly developing skeletonskeleton

BiochemistryBiochemistry

Page 20: Metabolic Bone Disease

Phosphate: Mesenchymal TumorPhosphate: Mesenchymal Tumor

Secretion of ‘Phosphatonins’Secretion of ‘Phosphatonins’molecules that reduce TmP and inhibit molecules that reduce TmP and inhibit mineralizationmineralization

BiochemistryBiochemistryP low; TmP low; FGF high; Ca normal; P low; TmP low; FGF high; Ca normal;

PTH PTH normal; Alk Ph normal; D normal; normal; Alk Ph normal; D normal; 25D 25D normal; 1,25 inappropriately normalnormal; 1,25 inappropriately normal

Page 21: Metabolic Bone Disease

Oncogenic OsteomalaciaOncogenic Osteomalacia

Page 22: Metabolic Bone Disease

Oncogenic OsteomalaciaOncogenic Osteomalacia

Page 23: Metabolic Bone Disease

Sporadic Hypophosphatemic Sporadic Hypophosphatemic Osteomalacia Osteomalacia

Page 24: Metabolic Bone Disease

Phosphate: Fanconi SyndromePhosphate: Fanconi Syndrome

Disease of the renal tubuleDisease of the renal tubulecan be genetic or acquired can be genetic or acquired

BiochemistryBiochemistryP low; TmP low; aminoaciduria; P low; TmP low; aminoaciduria;

glycosuria; Ca normal; PTH normal; glycosuria; Ca normal; PTH normal; Alk Ph normal; D normal; 25D Alk Ph normal; D normal; 25D normal; normal; 1,25D normal1,25D normal

Page 25: Metabolic Bone Disease

Phosphate: Phosphate: PHEXPHEX

X-linked Hypophosphatemic Rickets X-linked Hypophosphatemic Rickets FGF is a substrate for PHEX; FGF FGF is a substrate for PHEX; FGF

inhibits renal Na-P transporter inhibits renal Na-P transporter BiochemistryBiochemistry

P low; TmP low; FGF increased; Ca P low; TmP low; FGF increased; Ca normal; PTH normal; PTH normal; Alk Ph high; normal; Alk Ph high; D normal; 25D D normal; 25D normal; 1,25 D normal; 1,25 D

inappropriate normalinappropriate normal

Page 26: Metabolic Bone Disease

Phosphate: Phosphate: FGF 23FGF 23

Autosomal Dominant Hypophosphatemic Autosomal Dominant Hypophosphatemic RicketsRickets

BiochemistryBiochemistryP low; TmP low; FGF high; Ca P low; TmP low; FGF high; Ca

normal; PTH normal; Alk Ph high; D normal; PTH normal; Alk Ph high; D normal; 25D normal; 1,25D normalnormal; 25D normal; 1,25D normal

Page 27: Metabolic Bone Disease

CalciumCalcium

EnvironmentalEnvironmental insufficiency of dietary calcium insufficiency of dietary calcium during during rapid growthrapid growth

BiochemistryBiochemistry Ca low ; PTH high; Alk ph high; P Ca low ; PTH high; Alk ph high; P

low;low; D normal; 25D normal; 1,25 D high D normal; 25D normal; 1,25 D high

Page 28: Metabolic Bone Disease

AcidAcid

EnvironmentalEnvironmentalacquired renal tubular acidosis from renal acquired renal tubular acidosis from renal damagedamage

GeneticGenetic renal tubular acidosis renal tubular acidosis

BiochemistryBiochemistryHCO3 low; D normal; 25D normal; 1,25 D HCO3 low; D normal; 25D normal; 1,25 D low to normal; low to normal; Ca low; PTH high; Alk ph Ca low; PTH high; Alk ph high; P lowhigh; P low

Page 29: Metabolic Bone Disease

Alkaline PhosphataseAlkaline Phosphatase

GeneticGeneticHypophosphatasiaHypophosphatasia

BiochemistryBiochemistry Alk ph low; D normal; 25D normal; Alk ph low; D normal; 25D normal;

1,25 1,25 D normal; Ca normal; PTH normal; P D normal; Ca normal; PTH normal; P normalnormal

Page 30: Metabolic Bone Disease

HypophosphatasiaHypophosphatasia

Page 31: Metabolic Bone Disease

Drugs and ToxinsDrugs and Toxins

EnvironmentalEnvironmentalEtidronate; Fluoride; AluminumEtidronate; Fluoride; Aluminum

BiochemistryBiochemistry Alk ph normal ; D normal; 25D Alk ph normal ; D normal; 25D

normal; normal; 1,25 D normal; Ca normal; PTH 1,25 D normal; Ca normal; PTH normal; P normalnormal; P normal

Page 32: Metabolic Bone Disease

Low bone mineral content Low bone mineral content

OsteoporosisOsteoporosisDecreased volume of mineralized Decreased volume of mineralized

bone bone tissue pertissue per unit of boneunit of boneCortical thinning and increased Cortical thinning and increased

porosityporosity

Decreased number and thickness of Decreased number and thickness of trabeculae trabeculae Decreased bone strengthDecreased bone strength Increased risk of fractureIncreased risk of fracture

Page 33: Metabolic Bone Disease

Normal BoneNormal Bone

Female, age 30 years

Page 34: Metabolic Bone Disease

Moderate OsteoporosisModerate Osteoporosis

Female, age 88 years

Page 35: Metabolic Bone Disease

OsteoporosisOsteoporosis

Page 36: Metabolic Bone Disease

0.50

0.60

0.70

0.80

0.90

1.00

1.10

1.20

55-59 60-64 65-69 70-74 75-79 80-84 85-89

FemaleMale

0

500

1000

1500

2000

2500

65-69 70-74 75-79 80-84 85-89

2500

0

500

1000

1500

2000

Femoral Neck BMD ( ) and Hip Fracture ( )

Age (years)

BMD, g/cm2 Fractures/100,000/year

Kellie et al, AM J Pub Health 1990; 80:326

Page 37: Metabolic Bone Disease

Hip Fractures/100,000/year

0

500

1000

1500

2000

2500

3000

3500

65-69 70-74 75-79 80-84 85-89 90-94 95-99

White American FemaleBlack American FemaleJapanese Female

Age (years)

Kellie et al, AM J Pub Health 1990; 80:326-328Orimo et al, Osteoporosis 1990: Osteoporosis pp 56-61

Page 38: Metabolic Bone Disease

Fracture RiskFracture Risk

TraumaTrauma‘Normal’‘Normal’‘Minimal’‘Minimal’

Fracture RiskFracture Risk Age-relatedAge-related

Decreased bone strengthDecreased bone strengthAge/Sex/Race corrected: z scoreAge/Sex/Race corrected: z scoreYoung Adult Normal: t scoreYoung Adult Normal: t score1sd decrease doubles fracture risk1sd decrease doubles fracture risk

Page 39: Metabolic Bone Disease

OsteoporosisOsteoporosis GeneralizedGeneralized

corticalcorticaltrabeculartrabecular

LocalizedLocalizedrheumatoid arthritisrheumatoid arthritis

Bone marrow disease Bone marrow disease myelomamyelomasecondary cancersecondary cancerlymphoma and leukemialymphoma and leukemiamastocytosismastocytosishistiocytosishistiocytosis

Page 40: Metabolic Bone Disease

OsteoporosisOsteoporosis Age-related Age-related Hypogonadism: estrogen and testosteroneHypogonadism: estrogen and testosterone Calcium deficiency and insufficiencyCalcium deficiency and insufficiency Vitamin D deficiency and insufficiencyVitamin D deficiency and insufficiency Corticosteroid Treatment and Cushing’s DiseaseCorticosteroid Treatment and Cushing’s Disease ImmobilizationImmobilization Antiepileptic DrugsAntiepileptic Drugs MyelomaMyeloma ThyrotoxicosisThyrotoxicosis IdiopathicIdiopathic

Page 41: Metabolic Bone Disease

OsteoporosisOsteoporosis

Osteogenesis Imperfecta: COLA1,A2Osteogenesis Imperfecta: COLA1,A2 Phosphate DeficiencyPhosphate Deficiency Homocystinuria: cystathionine synthaseHomocystinuria: cystathionine synthase HeparinHeparin Pseudoganglioma syndrome: LRP 5 Pseudoganglioma syndrome: LRP 5

Page 42: Metabolic Bone Disease

High Bone Mineral ContentHigh Bone Mineral Content

OsteopetrosisOsteopetrosis Bisphosphonate TreatmentBisphosphonate Treatment Fluorosis Fluorosis Benign High Bone MassBenign High Bone Mass

Page 43: Metabolic Bone Disease

Benign High Bone MassBenign High Bone Mass

Page 44: Metabolic Bone Disease

Benign High Bone MassBenign High Bone Mass

Page 45: Metabolic Bone Disease

Benign High Bone MassBenign High Bone Mass

Page 46: Metabolic Bone Disease

OsteopetrosisOsteopetrosis

Infant OnsetInfant Onset Adult OnsetAdult Onset Carbonic Anhydrase 11 DeficiencyCarbonic Anhydrase 11 Deficiency

Page 47: Metabolic Bone Disease

Diseases of Bone TurnoverDiseases of Bone Turnover

Bone turnover is a term used to describe the Bone turnover is a term used to describe the rate of bone formation and resorption rate of bone formation and resorption

Bone resorption is coupled to bone formationBone resorption is coupled to bone formation During growth, turnover high, formation> During growth, turnover high, formation>

resorption, net bone gainresorption, net bone gain During adulthood, turnover moderate, During adulthood, turnover moderate,

formation< resorption, net bone lossformation< resorption, net bone loss

Page 48: Metabolic Bone Disease

Diseases of bone turnoverDiseases of bone turnover

High bone turnoverHigh bone turnoverPagets Pagets HyperparathyroidismHyperparathyroidism

Osteomalacia and ricketsOsteomalacia and ricketsThyrotoxicosisThyrotoxicosisHypogonadismHypogonadism

Low bone turnoverLow bone turnoverAdynamic bone disease; Adynamic bone disease; HypophosphatasiaHypophosphatasia

Page 49: Metabolic Bone Disease

Pagets DiseasePagets Disease

High bone turnoverHigh bone turnover High blood flowHigh blood flow Disordered bone architectureDisordered bone architecture Weakness of boneWeakness of bone

Page 50: Metabolic Bone Disease

Paget’s DiseasePaget’s Disease

Page 51: Metabolic Bone Disease

Hyperparathyroid diseaseHyperparathyroid disease

Primary Primary AdenomaAdenomaHyperplasiaHyperplasiaCancerCancer

SecondarySecondary

Calcium and Vitamin D insufficiencyCalcium and Vitamin D insufficiencyCalcium and Vitamin D deficiencyCalcium and Vitamin D deficiencyRenal FailureRenal Failure

Page 52: Metabolic Bone Disease

Secondary Hyperparathyroidism Secondary Hyperparathyroidism Renal osteodystrophyRenal osteodystrophy

Secondary/TertiarySecondary/TertiaryUremic mixed osteodystrophy Uremic mixed osteodystrophy Adynamic Adynamic FracturesFracturesEctopic calcificationEctopic calcification

Page 53: Metabolic Bone Disease

Hip fracture in dialysis:Hip fracture in dialysis: ( (6,532 # in 326,463 patients)6,532 # in 326,463 patients) Alem et al Alem et al

Kid Inter: 2000;58,396 Kid Inter: 2000;58,396

0

2

4

6

8

10

12

14

16

18

per 1000 person years

women

men

relative risk 4.4

Page 54: Metabolic Bone Disease

Mixed uremic osteodystrophyMixed uremic osteodystrophy

Increased Increased activation frequencyactivation frequencybone formation ratebone formation ratemarrow fibrosismarrow fibrosisosteoblastsosteoblastsosteoclastsosteoclasts

Page 55: Metabolic Bone Disease

Ectopic calcificationEctopic calcification

Calcium x Phosphate productCalcium x Phosphate product Vascular systemVascular system SkinSkin CartilageCartilage

Page 56: Metabolic Bone Disease

Recommended